World's Best Scientists 2026 revealed!
Meinoshin Okumura

Meinoshin Okumura

D-Index & Metrics

Medicine

D-Index
80
Citations
26441
World Ranking
17015
National Ranking
539

Meinoshin Okumura publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Meinoshin Okumura sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 499 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Meinoshin Okumura D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Meinoshin Okumura sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Meinoshin Okumura is affiliated with Osaka University in Japan and has contributed extensively to the field of Medicine, particularly focusing on pulmonary and respiratory medicine, neurology, oncology, surgery, and endocrinology. Their research spans several specialized areas including lung cancer diagnosis and treatment, myasthenia gravis and thymoma, pleural and pulmonary diseases, and disorders related to the pituitary gland.

The scientist has authored numerous papers featured in journals with a focus on thoracic oncology and respiratory medicine. Frequent publication venues include:

  • Journal of Thoracic Oncology
  • Surgery Today
  • Mediastinum
  • Cancer Science
  • Lung Cancer

Key recent papers authored by or involving Meinoshin Okumura include:

  • Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer, 2020, Science Immunology
  • Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape, 2021, Science Immunology
  • Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases, 2020, The Annals of Thoracic Surgery
  • IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer, 2023, Journal of Thoracic Oncology
  • Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma, 2022, Nature Communications

The scientist's frequent co-authors include:

  • Yasushi Shintani (22 collaborations)
  • Soichiro Funaki (16 collaborations)
  • Hisao Asamura (13 collaborations)
  • Hiroshi Date (8 collaborations)
  • Ichiro Yoshino (8 collaborations)

The main fields of study for Meinoshin Okumura are Medicine, with a strong focus on subfields such as pulmonary and respiratory medicine, neurology, oncology, surgery, and endocrinology, diabetes, and metabolism. Their research covers topics including:

  • Myasthenia Gravis and Thymoma
  • Lung Cancer Diagnosis and Treatment
  • Pleural and Pulmonary Diseases
  • Lung Cancer Treatments and Mutations
  • Pituitary Gland Disorders and Treatments
  • Lung Cancer Research Studies
  • Meningioma and schwannoma management

Best Publications

  • The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

    Peter Goldstraw;Kari Chansky;John Crowley;Ramon Rami-Porta

  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    James F Howard;Kimiaki Utsugisawa;Michael Benatar;Hiroyuki Murai

  • The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients.

    Meinoshin Okumura;Mitsunori Ohta;Hisashi Tateyama;Katsuhiro Nakagawa

  • The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

    William D. Travis;Hisao Asamura;Alexander A. Bankier;Mary Beth Beasley

  • Thoracic and cardiovascular surgery in Japan during 2014 : Annual report by The Japanese Association for Thoracic Surgery.

    Munetaka Masuda;Meinoshin Okumura;Yuichiro Doki

  • The IASLC/ITMIG thymic epithelial tumors staging project : proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors

    Frank C. Detterbeck;Kelly Stratton;Dorothy Giroux;Hisao Asamura

  • Immunohistochemical detection of WT1 protein in a variety of cancer cells

    Shin-ichi Nakatsuka;Yusuke Oji;Tetsuya Horiuchi;Takayoshi Kanda

  • Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over Decade

    Noriyoshi Sawabata;Etsuo Miyaoka;Hisao Asamura;Yoichi Nakanishi

  • IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.

    Yasushi Shintani;Ayako Fujiwara;Toru Kimura;Tomohiro Kawamura

  • The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

    Frank C. Detterbeck;Wilbur A. Franklin;Andrew G. Nicholson;Nicolas Girard

  • The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer

    Frank C. Detterbeck;Kari Chansky;Patti Groome;Vanessa Bolejack

  • Long-term outcomes after a variety of video-assisted thoracoscopic lobectomy approaches for clinical stage IA lung cancer: A multi-institutional study

    Norihisa Shigemura;Akinori Akashi;Soichiro Funaki;Tomoyuki Nakagiri

  • The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification

    Frank C. Detterbeck;Andrew G. Nicholson;Wilbur A. Franklin;Edith M. Marom

  • Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors.

    Meinoshin Okumura;Shinichiro Miyoshi;Yoshitaka Fujii;Yukiyasu Takeuchi

  • Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension

    Takahiro Hashimoto-Kataoka;Naoki Hosen;Takashi Sonobe;Yoh Arita

  • Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay

    Katsuhiko Endo;Akimitsu Konishi;Hidefumi Sasaki;Minoru Takada

  • Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer.

    Yasushi Shintani;Akira Okimura;Katsutoshi Sato;Tomoyuki Nakagiri

  • Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings.

    Noriyuki Tomiyama;Takeshi Johkoh;Naoki Mihara;Osamu Honda

  • Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo.

    Tomohiro Kawamura;Nobunao Wakabayashi;Norihisa Shigemura;Chien Sheng Huang

  • Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer

    Eri Sugiyama;Yosuke Togashi;Yoshiko Takeuchi;Sayoko Shinya

Frequent Co-Authors

Hikaru Matsuda
Hikaru Matsuda Osaka University
Hisao Asamura
Hisao Asamura Keio University
Yoshiki Sawa
Yoshiki Sawa Osaka University
Yoshitaka Fujii
Yoshitaka Fujii Nagoya City University
Eiichi Morii
Eiichi Morii Osaka University
Masaki Mori
Masaki Mori Kyushu University
Kenji Kangawa
Kenji Kangawa National Cerebral and Cardiovascular Center
Hiroshi Hosoda
Hiroshi Hosoda Shinshu University
Shinichi Toyooka
Shinichi Toyooka Okayama University
Shin'ichi Takeda
Shin'ichi Takeda National Center of Neurology and Psychiatry

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a career in Medicine doesn’t always follow a traditional route. Many students seek alternative programs and flexible online degrees to meet their goals or adapt to personal circumstances. For those looking to advance in nursing without the pressure of rigorous entrance exams, there are lpn to rn programs without teas test, which allow licensed practical nurses to progress without standardized test barriers.

Beyond clinical roles, healthcare administration offers another avenue for making a difference. With a healthcare administration associate degree online, students can prepare for management roles in hospitals, clinics, and public health organizations.

Nurses aiming to take on advanced responsibilities might consider rn to np bridge programs that streamline the pathway from registered nurse to nurse practitioner, opening new doors in clinical leadership and specialized care.

Nutrition is another growing field closely related to Medicine. Earning an online bachelor's in nutrition lets students explore roles in dietetics, wellness, and preventative healthcare—all from the flexibility of an online program. These pathways provide diverse, rewarding options for anyone interested in health sciences.

Best Scientists Citing Meinoshin Okumura

Trending Scientists

Recently Published Articles